Joint modeling of an outcome variable and integrated omics datasets using GLM-PO2PLS

In many studies of human diseases, multiple omics datasets are measured. Typically, these omics datasets are studied one by one with the disease, thus the relationship between omics is overlooked. Modeling the joint part of multiple omics and its association to the outcome disease will provide insig...

Full description

Saved in:
Bibliographic Details
Published inJournal of applied statistics Vol. 51; no. 13; pp. 2627 - 2651
Main Authors Gu, Zhujie, Uh, Hae-Won, Houwing-Duistermaat, Jeanine, el Bouhaddani, Said
Format Journal Article
LanguageEnglish
Published Abingdon Taylor & Francis 02.10.2024
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In many studies of human diseases, multiple omics datasets are measured. Typically, these omics datasets are studied one by one with the disease, thus the relationship between omics is overlooked. Modeling the joint part of multiple omics and its association to the outcome disease will provide insights into the complex molecular base of the disease. Several dimension reduction methods which jointly model multiple omics and two-stage approaches that model the omics and outcome in separate steps are available. Holistic one-stage models for both omics and outcome are lacking. In this article, we propose a novel one-stage method that jointly models an outcome variable with omics. We establish the model identifiability and develop EM algorithms to obtain maximum likelihood estimators of the parameters for normally and Bernoulli distributed outcomes. Test statistics are proposed to infer the association between the outcome and omics, and their asymptotic distributions are derived. Extensive simulation studies are conducted to evaluate the proposed model. The method is illustrated by modeling Down syndrome as outcome and methylation and glycomics as omics datasets. Here we show that our model provides more insight by jointly considering methylation and glycomics.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Supplemental data for this article can be accessed online at https://doi.org/10.1080/02664763.2024.2313458.
ISSN:0266-4763
1360-0532
DOI:10.1080/02664763.2024.2313458